Cannabis
Alt Thirty Six Secures $10 Million In Series A Funding For Cannabis Payment Solution Platform
Alt Thirty Six, a first-of-its-kind digital payment and compliance platform designed to help the cannabis industry go cashless, announces $10 million in Series A funding to help accelerate company growth and enhance development capabilities. The round was led by a private equity firm to support Alt Thirty Six‘s digital payment solution.
The company’s innovative platform eliminates the need for cash in the cannabis industry by using blockchain technology and Dash, a decentralized digital asset, to facilitate the transfer of funds at dispensaries and cannabis businesses.
Alt Thirty Six will use the funding to further drive company expansion, advance the platform’s technical functions and abilities, expand proper licensing in target states across the U.S., while maintaining focus on compliance and regulation. Ultimately, the capital will be used to help Alt Thirty Six achieve mass consumer adoption throughout the cannabis industry.
“We are committed to revolutionizing the cannabis space by increasing access to compliant digital payments, making transactions easier and faster for all cannabis businesses,” said Ken Ramirez, co-founder and CEO of Alt Thirty Six. “This new Series A funding round provides us access to the resources we need to help facilitate our vision for one of the fastest growing industries in the country.”
Alt Thirty Six‘s recent company announcements include a partnership with CannTrade, a leading provider of cannabis software technology, and the hiring of Chief Architect Jason Breidis, a payments expert whose work led to the acceptance of electronic payments at McDonald’s restaurants and is used to process billions of dollars in transactions.
“We fully support Alt Thirty Six‘s innovative payment technology and dedication to providing the cannabis industry with an alternative to cash,” says the private equity firm. “We are thrilled to lead this funding round. Alt Thirty Six brings a new, payments-focused element to our portfolio, adding tremendous value to the cannabis businesses.”
SOURCE Alt Thirty Six
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf5 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care